The Open University
Investigating the potential role of a human long non-coding RNA with ‘accelerated evolution’ in neurodevelopment and gliomas
Abstract
dc:description.abstractLong non-coding RNAs (lncRNAs) have a wide range of functions in health and disease, but many remain uncharacterised. Human accelerated region 1 (<i>HAR1</i>) and HAQER0035 are stretches of genomic DNA that, in humans, have significantly altered base sequences relative to chimpanzees. <i>HAR1A</i> and <i>HAR1B</i> are overlapping lncRNAs containing these sequences, and their expression has been shown to be regulated by the RE1 silencing transcription factor (REST). The functions of these lncRNAs are largely unknown, but they have been associated with neurodevelopment and neurological disorders. In cancers, low expression of <i>HAR1A</i> and <i>HAR1B</i> is correlated with glioma progression and poor patient prognosis.<br></br><br></br> The aim of this study was to characterise and investigate the role of <i>HAR1A</i> and <i>HAR1B</i> in the context of the healthy or diseased human nervous system. The expression patterns of <i>HAR1A, HAR1B</i> and <i>REST</i> were investigated <i>in silico</i> using a developing human brain and clinical glioma datasets, revealing an inverse correlation between the lncRNAs and <i>REST</i>. The expression of the lncRNAs increases postnatally, in structures relevant to memory and sensory processing, and their low expression correlates with advanced glioma grade and poor prognosis. Gene ontology analysis found the most enriched process associated with <i>HAR1</i> expression to be chemical synaptic signalling.<br></br><br></br> Following the <i>in silico</i> analysis, the expression and function of <i>HAR1A</i> was analysed in a neural progenitor cell line (ReN VM) that could be readily differentiated into astrocytes and dopaminergic neurons, and in multiple brain cancer cell lines (U-373, SH-SY5Y, DIPGA, GIN28, GCE28). Key studies determined the subcellular localisation of <i>HAR1A</i>to be nuclear. Upon ReN cell differentiation, the expression of <i>HAR1A</i>was found to decrease within 12 hours, independent of the locus, though cell distribution did not change from baseline. <i>HAR1A</i>was expressed via lentiviral overexpression, and its subcellular localisation confirmed to be retained in the nucleus. In ReN cells, proliferation, migration assays, KCl incubation and assessment of nuclear morphology by TEM identified little observable effect of <i>HAR1A</i> overexpression. In U-373 cells, <i>HAR1A</i> expression was increased with siRNA silencing of <i>REST</i>, but the reduction in cell proliferation observed was not correlated with <i>HAR1A</i> overexpression. Similar to ReN, little observable effect of <i>HAR1A</i>overexpression was found when analysing proliferation, migration and nuclear morphology.<br></br><br></br> This study has revealed that <i>HAR1A</i> is not involved in widely measured phenotypes, however, the rapid degradation associated with differentiation suggest that <i>HAR1A</i> plays a role in maintaining a less specialised, or early neuronal cell type.<br></br>
Degree
thesis:*- Name dc:type.qualificationname
- phd
- Level dc:type.qualificationlevel
- doctoral
- Grantor dc:publisher.institution
- The Open University
- Year dc:date.issued
- 2024
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Waters, Ella
Rights
- Language dc:language
- en